Critical Appraisal II Prepared by Dr. Hoda Abd El Azim.

Slides:



Advertisements
Similar presentations
Evidence Based Practice MMR Vaccine Who Has Concerns About the Safety of This Vaccine?
Advertisements

How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Protocol Development.
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Cross Sectional Designs
Integration: Intersection for Reproductive Health and HIV Programs: the Kenyan Experience Family Health International Sponsored Satellite Session World.
Case-Control Studies (Retrospective Studies). What is a cohort?
Teenage conceptions in Wales The challenge of intervention and evaluation.
The Family Planning Clinic. For each of the cases Consider the factors raised by the case Advise about options, including alternatives.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
1. 2 Implementing and Evaluating of an Evidence Based Nursing into Practice Prepared By Dr. Nahed Said El nagger Assistant Professor of Nursing H.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
1Carl-Fredrik Burman, 11 Nov 2008 RSS / MRC / NIHR HTA Futility Meeting Futility stopping Carl-Fredrik Burman, PhD Statistical Science Director AstraZeneca.
Research problem, Purpose, question
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
EVIDENCE BASED MEDICINE
Critical Appraisal of an Article by Dr. I. Selvaraj B. SC. ,M. B. B. S
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
Baltic Dental Meeting Palanga Dana Romane The Patient in the Centre – Patient’s Involvement in the Treatment Process, Full Awareness and.
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
Are exposures associated with disease?
Critical Appraisal of Clinical Practice Guidelines
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Are the results valid? Was the validity of the included studies appraised?
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Screening and Prevention of Illnesses and Injuries: Research Methods.
Systematic Reviews.
EVIDENCE BASED MEDICINE Effectiveness of therapy Ross Lawrenson.
S7: Audit Planning. Session Objectives To explain the need for planning To explain the need for planning To outline the essential elements of planning.
Audit Planning. Session Objectives To explain the need for planning To outline the essential elements of planning process To finalise the audit approach.
Appraising Evidence into our Practice. Objectives Deciding the research result into practice in specific context Interpreting/calculating Number Needed.
Copyright ©2006 Brooks/Cole, a division of Thomson Learning, Inc. Relationships Between Categorical Variables Chapter 6.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2012.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Research Methodology Chapter 1 Dr. Areefa Albahri Assistant Professor.
Barriers to EBP Prepared by: Dr. Hoda Abed El-Azim.
Describing the risk of an event and identifying risk factors Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
A Simple Method for Evaluating the Clinical Literature “PP-ICONS” approach Based on Robert J. Flaherty - Family Practice Management – 5/2004.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
By MUREREREHE Julienne BDT(Hons) KHI..  Informed consent is a legal document, prepared as an agreement for treatment, non-treatment, or for an invasive.
EBM --- Journal Reading Presenter :黃美琴 Date : 2005/10/27.
Critical Appraisal of a Paper Feedback. Critical Appraisal Full Reference –Authors (Surname & Abbreviations) –Year of publication –Full Title –Journal.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Evidence Informed Public Health
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
for Overall Prognosis Workshop Cochrane Colloquium, Seoul
Assistant professor Family Medicine - Suez Canal University
Critically Appraising a Medical Journal Article
Week 5: Ethical, Legal & Social Issues in Applied Genomics
The NICE Citizens Council and the role of social value judgements
Critical Reading of Clinical Study Results
Laura Reichenbach, Evidence Project, Population Council
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Monitoring and evaluation Part 1 Lecture 10. Appraisal Vs Evaluation  Appraisal is before an activity takes place  Evaluation after the activity has.
Evidence Based Diagnosis
Presentation transcript:

Critical Appraisal II Prepared by Dr. Hoda Abd El Azim

Lecture VII

Learning Objectives:  Identify the questions used for assessing applicability of the study.  Identify how to decide whether the results from a study can be applied.

Can the evidence be applied in your context?  How to decide whether the results from a study can be applied to your patients in your workplace.  How you can translate the results given for a study sample into clinically meaningful results for the individual patient.

Deciding whether the results can be applied in your setting!  Health related research takes place all over the world, in setting that may be very different from the one in which your clients are found.  Research is carried out on sample from the wider population.  Health care practitioners need to be able to decide whether the results obtained in a study can be applied to their patient.

Seek to include not exclude studies The patient and settings used in a research study will never be identical to yours.

When considering the issue of applicability it is more useful to ask the question Are my patient/ setting so different that results will not apply? Than ask: Are these patient exactly the same age, gender, etc. as the patient in my clinic ward? If there are a differences ask How these differences might affect the results?

If the differences would only change the size or extent of the effect of the treatment, rather than changing the effect from one of benefit to one of harm. It may be possible to adjust the result to reflect the impact in your patients.

Questions for assessing applicability and screening  Is it clear what the study is about?  Is the sample/ context adequately described?  Are my clients sufficiently different that results won’t apply?  Is the action indicated or the intervention available or the change possible in my setting?

 Do the benefits of any change for my patient context be more important than the likely costs?  Are the client’s values and preferences satisfied by change?

What are the factors to consider when assessing applicability ? 1. The characteristics of the participants in the study (those factors that could potentially affect the outcomes of interest) 2. Is it possible to apply the intervention or test described in the study? 1. Costs and benefits of the intervention.

Cont., 4. Where the cost are being too high, the proposed change is unlikely to be accepted. 5. Client preference needs to be taken into account. Client may have strong preference for or against a particular intervention (forcing a client to use the intervention indicated by evidence would be unethical).

Example: Situation : Florence Barrett, 35 years old, mother of two, used oral contraception for the last 10 years, smoke cigarettes per day.

Clinical question: Is Florence a heavy smoker using the oral contraceptive pill, at higher risk of myocardial infarction than women who smoke but use other forms of contraception?

Evidence: Manta J., & others 1998, risk of myocardial infarction, angina, and stroke in users of oral contraceptives: an updated analysis of a cohort study. British journal of obstetrics and gynecology 105:

Question for assessing the applicability of a study What is the study about? The study investigated the risk of myocardial infarction, angina, and stroke in users of oral contraceptives compared with users of other methods.

Who are the participants in the study? The study include women aged 25-39, smokers and non smokers were included. In what way are our client different? Those study participants who smoke can be assumed to be similar to Florence Barrett.

Is the change indicated possible in our setting? If the results suggested that Florence was at greater risk of an MI if she continued to use OCM there are no problem to change the method of contraception Florence uses far from her own preferences.

What are the benefits of the change indicated to whom? The potential benefit to Florence is a reduction in her risk of MI.

What are the costs (financial or otherwise) of the change and to whom?  Potential costs to Florence and her family include increased risk of unwanted pregnancy  suitable methods of contraception might stopped.

In what ways do the change indicated meet with your client’s values and preferences? No information is given about Florence’s preferred method of contraception.

What do the results of this study mean in may context for my clients? Once you have decided the quality of the study is good enough, and the results can be applied to your client, the next stage is to interpret what the results of the study mean for your client.

Thank You